50mgx6 tabletsx2 plates/box national drug approval number H20061237

Introduction

Effective against the following infections caused by Streptococcus spp. (except enterococci), Pneumococcus, Gonococcus, Cataplasmosis, Escherichia coli, Klebsiella spp., Serratia spp., Aspergillus spp., and Influenza bacillus from cefixime-susceptible bacteria. Acute exacerbation of chronic bronchitis, acute bronchitis with exacerbation of bacterial infection, bronchodilatation co-infection, pneumonia; pyelonephritis, cystitis, gonococcal urethritis; acute bacterial infections of the biliary tract system (cholecystitis, cholangitis) scarlet fever; otitis media, sinusitis.